MUMBAI (Reuters) - Japan's Daiichi Sankyo Company Ltd (4568.T) is selling its stake worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd (SUN.NS), a person directly involved in the deal said on Monday.
The Japanese company is selling its 8.9 percent stake in Sun Pharma, India's largest drugmaker by sales, via block deals on the Indian exchanges, said the person, who declined to be named as he was not authorized to speak to the media.
04:18 NAB, Oxley to sell stakes in Cambridge Industrial manager to e-Shang Redwood15
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese9
00:39 Former Canadian Pacific CEO Harrison, Paul Hilal in talks for CSX stake16
11:20 PE firm Warburg buys $121 million stake in Indian cinema operator PVR13